menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    17 January 2017 M36 meeting in Brussels

    To allow presentation of project results and direct interaction with our Project Officer, TumAdoR consortium will organized its M36 biannual meeting in Brussels.More >>


    17 January 2017 M30 meeting in San Antonio

    We had a gren ligh to meet in Texas. The meeting wll be organized by THSCSA on 9 and 1àth of March 2016.More >>


    Displaying results 3 to 4 out of 7
    Brochure